24 Results for "

Hmox1

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "Hmox1" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-N0643
CAS No.: 5957-80-2
Carnosol is a potent Ribosomal S6 Kinase (RSK2) inhibitor that could be useful for treating gastric cancer, with an IC50 of ~5.5 μM [1]. Carnosol, a Nrf2 activator, increases the nuclear levels of Nrf2 and can promote the expression of heme oxygenase 1 (HMOX1) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70276
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Hmox1; Heme Oxygenase; Heme Oxygenase 1; Hmox1D; HO-1; HSP32; BK286B10; HO1; Heme Oxygenase (Decycling) 1; HO; Heat Shock Protein, 32-KD
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3001
CAS No.: 957-66-4
Isolinderalactone is a sesquiterpene that exhibits anti-cancer, anti-inflammatory, and neuroprotective effects. Isolinderalactone inhibits VEGF expression and tyrosine phosphorylation of VEGFR2. Isolinderalactone decreases viability and induces apoptosis in U-87 glioblastoma (GBM) cells and colorectal cancer (CRC) cells. Isolinderalactone induces G2/M phase cell cycle arrest, ROS generation, pJNK/p38 MAPK activation, in colorectal cancer (CRC) cells. Isolinderalactone blocks LPS (HY-D1056)-induced NF-κB activation while activating Nrf2-HMOX1 signaling in RAW264.7 macrophages. Isolinderalactone improves cognitive dysfunction in APP/PS1 mice. Isolinderalactone can be used for the study of Glioblastoma multiforme (GBM), colorectal cancer, Alzheimer’s disease and acute lung injury [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80499

Host:  

Rabbit

Application:  

WB, IHC-P, IP, FC

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-167874
CAS No.: 2488255-42-9
ASP-8731 is an orally active BACH1 inhibitor. ASP-8731 activates antioxidant, anti-inflammatory and globin gene pathways by relieving the inhibitory effect of BACH1 on NRF2-mediated gene transcription. ASP-8731 significantly upregulates the expression of HMOX1, FTH1 and various globins (such as HGB, HBG, HBA), increases fetal hemoglobin (HbF) levels, and effectively induces F-cell production in hydroxyurea-unresponsive cells. Meanwhile, ASP-8731 reduces inflammatory responses and white blood cell counts by downregulating VCAM1, ICAM-1 and the phosphorylation level of NF-κB(p65), and blocks heme-induced glutathione depletion and microcirculatory stasis. ASP-8731 holds potential for inhibiting sickle cell disease and related hematological disorders [1].
loading...
    loading...
Cat. No.: HY-124529
CAS No.: 37116-80-6
Lunularin is an inhibitor of 11β-hydroxysteroid dehydrogenase 1, with an IC50 of 45.44 μM and a Ki of 35.8 μM against human 11β-HSD1, and an IC50 of 17.39 μM and a Ki of 10.31 μM against rat 11β-HSD1. Lunularin upregulates the transcription levels of Sirt1 and Hmox1 genes in the liver. Lunularin reduces food intake and body weight gain, and decreases blood glucose levels in mice fed a high-fat diet. Lunularin inhibits LPS-induced TLR4-mediated NF-κB pathway activation and nitric oxide production. Lunularin inhibits the proliferation and colony formation of renal cancer and colon cancer cells, and exhibits cancer cell-specific cytotoxicity. Lunularin binds to the steroid-binding site of human 11β-HSD1 and the steroid/NADPH-binding region of rat 11β-HSD1, but does not inhibit 11β-HSD2 or mouse 11β-HSD1. Lunularin can be used in research related to diet-induced obesity, renal cancer, colorectal cancer, inflammatory diseases and metabolic syndrome [1] .
loading...
    loading...
Cat. No.: HY-RS06249
Research Areas:  

Others

HMOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for HMOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16718
Research Areas:  

Others

Hmox1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hmox1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-147517
CAS No.: 2769963-24-6
Purity:  98.52%
Target:  

Keap1-Nrf2

Keap1-Nrf2-IN-9 (Compound 11) is a potent Keap1-Nrf2 PPI (Keap1-Nrf2 protein-protein interaction) inhibitor with an IC50 of 0.575 μM. Keap1-Nrf2-IN-9 increases the expression of Nrf2 target genes including heme oxygenase 1 (Hmox1), glutathione S-transferase P (GstP), and glutamate-cysteine ligase catalytic (Gclc) and modulatory (Gclm) subunits. Keap1-Nrf2-IN-9 shows no cytotoxic activity in ARPE19 cells [1].
loading...
    loading...
Cat. No.: HY-124815
CAS No.: 895470-67-4
Purity:  99.69%
Research Areas:  

Others

CP-312 is a potent Heme Oxygenase-1 (HO-1) inducer. CP-312 protects hiPSC-CM viability by targeting the antioxidant response network through induction of HMOX1 expression. CP-312 protects human iPSC-derived cardiomyocytes from oxidative stress [1].
loading...
    loading...
Cat. No.: HY-RS23153
Research Areas:  

Others

Hmox1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hmox1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-175806
CAS No.: 1372792-51-2
Research Areas:  

Cancer

CS47 is a Thioredoxin Reductase 1 (TRXR1) inhibitor and ferroptosis inducer. CS47 binds non-covalently to sites between the FAD and NADPH pockets of TRXR1. CS47 drives glutathione depletion, lipid reactive oxygen species accumulation, HMOX1-dependent iron overload, and selective cytotoxicity in lung cancer cells. CS47 can be used for the research of lung cancer [1].
loading...
    loading...
Cat. No.: HY-173444
CAS No.: 2989934-63-4
Research Areas:  

Cancer

HDAC11-IN-3 (Compound A9) is a selective HDAC11 inhibitor (IC50: 4.1 nM). HDAC11-IN-3 has inhibitory effects on U937 and OCI-AML2 acute myeloid leukemia (AML) cell lines (IC50: 10 μM). HDAC11-IN-3 has significant anti-AML activity, inducing apoptosis, cell cycle arrest, and differentiation. HDAC11-IN-3 upregulates the iron transporters transferrin (TF) and transferrin receptor (TFRC), and activates the p62-Keap1-Nrf2-HMOX1 pathway, which together lead to increased intracellular iron levels and induce ferroptosis in AML cells. HDAC11-IN-3 can be used alone or in combination with Cytarabine (HY-13605) for AML research [1].
loading...
    loading...
Cat. No.: HY-121523
CAS No.: 345989-24-4
Purity:  99.93%
Target:  

Keap1-Nrf2

Research Areas:  

Metabolic Disease

MIND4-17 is a potent NRF2 activator that covalently modifies a C151 residue of Keap1. MIND4-17 disrupts Keap1-Nrf2 association, leading to Nrf2 protein stabilization and nuclear translocation. MIND4‐17 exerts potent antioxidant activity [1] .
loading...
    loading...
Cat. No.: HY-N0643R
CAS No.: 5957-80-2
Carnosol (Standard) is the analytical standard of Carnosol. This product is intended for research and analytical applications. Carnosol is a potent Ribosomal S6 Kinase (RSK2) inhibitor that could be useful for treating gastric cancer, with an IC50 of ~5.5 μM [1]. Carnosol, a Nrf2 activator, increases the nuclear levels of Nrf2 and can promote the expression of heme oxygenase 1 (HMOX1) .
loading...
    loading...
Cat. No.: HY-124815R
CAS No.: 895470-67-4
Research Areas:  

Others

CP-312 (Standard) is the analytical standard of CP-312. This product is intended for research and analytical applications. CP-312 is a potent Heme Oxygenase-1 (HO-1) inducer. CP-312 protects hiPSC-CM viability by targeting the antioxidant response network through induction of HMOX1 expression. CP-312 protects human iPSC-derived cardiomyocytes from oxidative stress [1].
loading...
    loading...
Cat. No.: HY-184288
Nrf-2/HMOX-1-IN-1 is a Nrf-2 and HMOX-1 inhibitor, as well as a Ferroptosis inducer. Nrf-2/HMOX-1-IN-1 inhibits GPX activity and upregulates p53 gene expression. Nrf-2/HMOX-1-IN-1 increases intracellular ROS and MDA levels, reduces GSH content, and elevates intracellular iron levels simultaneously. Nrf-2/HMOX-1-IN-1 exerts selective anticancer effects against breast cancer. Nrf-2/HMOX-1-IN-1 can be used in breast cancer-related research [1].
loading...
    loading...
Cat. No.: HY-P706203
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Heme oxygenase 1; EC:1.14.14.18; HO-1; HSP32; Heme oxygenase 1 soluble form 1 publication; Hmox1
Species:  
Rat
Source:  
loading...
    loading...
Cat. No.: HY-170968
CAS No.: 3037323-16-0
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR-IN-150 is an EGFR inhibitor that effectively suppresses the phosphorylation of mutant epidermal growth factor receptor (EGFR) and its downstream AKT signaling pathway, thereby exerting antitumor effects and inducing HMOX1 expression to trigger ferroptosis. EGFR-IN-150 exhibits an IC50 of 0.386 μM against the non-small cell lung cancer (NSCLC) cell line H1975, and significantly inhibits colony formation and migration of both H1975 and A549 cells while inducing apoptosis. In addition, EGFR-IN-150 markedly suppresses tumor growth in the H1975 cell-derived xenograft (CDX) mouse model. EGFR-IN-150 holds promise for research related to non-small cell lung cancer [1].
loading...
    loading...
Cat. No.: HY-P700495
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Hmox1; Heme Oxygenase; Heme Oxygenase 1; Hmox1D; HO-1; HSP32; BK286B10; HO1; Heme Oxygenase (Decycling) 1; HO; Heat Shock Protein, 32-KD
Species:  
Source:  
loading...
    loading...